Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jellinger

Showing results (321-330 of 364) with videos related to

Pageof 37
Sort By:
Zentralblatt Fur Neurochirurgie|January 1, 1981
Multimodality treatment of malignant gliomas. Comparison of several adjuvant approachesK Jellinger, D Volc, W Grisold, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 1999
Progression of falls in postmortem-confirmed parkinsonian disordersG K Wenning, G Ebersbach, M Verny, et al.
Archives of Neurology|February 15, 2001
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disordersJ Müller, G K Wenning, M Verny, et al.
Wiener Klinische Wochenschrift|March 5, 1976
[Neuropathology of renal transplantation (author's transl)]H Budka, K Jellinger, A Wolf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
Schizophrenia: normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2P Seeman, K Ohara, C Ulpian, et al.
Neuroscience|August 5, 2000
Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy)C Scherfler, Z Puschban, I Ghorayeb, et al.
Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.
Neuroscience|January 1, 1992
Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesiclesH Lassmann, R Weiler, P Fischer, et al.
Annals of Neurology|September 8, 2000
No tissue damage by chronic deep brain stimulation in Parkinson's diseaseC Haberler, F Alesch, P R Mazal, et al.
Regulatory Peptides|August 30, 2008
Chromogranin peptides in amyotrophic lateral sclerosisA Schrott-Fischer, M Bitsche, C Humpel, et al.
Pageof 37

Showing results (321-330 of 364) with videos related to

Sort By:
Pageof 37
Zentralblatt Fur Neurochirurgie|January 1, 1981
Multimodality treatment of malignant gliomas. Comparison of several adjuvant approachesK Jellinger, D Volc, W Grisold, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 1999
Progression of falls in postmortem-confirmed parkinsonian disordersG K Wenning, G Ebersbach, M Verny, et al.
Archives of Neurology|February 15, 2001
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disordersJ Müller, G K Wenning, M Verny, et al.
Wiener Klinische Wochenschrift|March 5, 1976
[Neuropathology of renal transplantation (author's transl)]H Budka, K Jellinger, A Wolf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
Schizophrenia: normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2P Seeman, K Ohara, C Ulpian, et al.
Neuroscience|August 5, 2000
Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy)C Scherfler, Z Puschban, I Ghorayeb, et al.
Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.
Neuroscience|January 1, 1992
Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesiclesH Lassmann, R Weiler, P Fischer, et al.
Annals of Neurology|September 8, 2000
No tissue damage by chronic deep brain stimulation in Parkinson's diseaseC Haberler, F Alesch, P R Mazal, et al.
Regulatory Peptides|August 30, 2008
Chromogranin peptides in amyotrophic lateral sclerosisA Schrott-Fischer, M Bitsche, C Humpel, et al.
Pageof 37